-
PUBLICATION
Drug Efficacy Study in the STAM™ Model Published in Gene
2022.10.05
SMC is proud to announce that TSUMURA & CO. (JPN) has published the results of their study using our STAM™ model in Gene.
-
UPCOMING EVENTS
SMC participate The BioJapan Partnering!
2022.09.28
We are pleased to announce that SMC Laboratories will be participating the BioJapan Partnering Event from October 12th (Wed) to 14th (Fri).
-
NEWS RELEASE
Today, September 21th, is World Alzheimer’s Day!
2022.09.21
We recently mentioned World Alzheimer's Month, including World Alzheimer's Day (Previous article), and today we would like to share SMC's thoughts on the development of a medicine for the treatment of Alzheimer's disease.
-
NEWS RELEASE
The importance of the NAFLD activity score and the STAM™ model’s clinical relevance
2022.09.14
In this issue, we would like to introduce the NAFLD activity score (NAS), which is one of the main endpoints used in the development of drug candidates for NASH, and the role it plays in our proprietary STAM™ model.
-
PRODUCTS AND SERVICES
Introducing our Idiopathic Pulmonary Fibrosis (IPF) mouse model
2022.09.07
The outbreak of COVID-19 causes a lot of complications and long-term harm to the patient, especially severe pulmonary fibrosis.
-
NEWS RELEASE
September is World Alzheimer’s Month!
2022.08.31
In recognition of September 21st being World Alzheimer’s Day, why don’t we deepen our understanding of Alzheimer's disease?
-
UPCOMING EVENTS
SMC attend The Biotechgate Digital Partnering!
2022.08.24
We are pleased to announce that SMC Laboratories will be virtually attending the Biotechgate Digital Partnering from August 29th to September 2nd.
-
UPCOMING EVENTS
SMC attend The 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching!
2022.08.17
We are pleased to announce that SMC Laboratories will be virtually attending the 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching on September 2nd.
-
PUBLICATION
A study using liver samples from the STAM™ model published in PLOS ONE.
2022.08.10
SMC is proud to announce that Institut de Recherches Servier (FRA) has published the results of their study using our STAM™ model liver samples in PLOS ONE.
-
PUBLICATION
2022.08.03
Today, we are pleased to announce the acceptance of our abstract on our NASH-hepatocellular carcinoma (HCC) model at the International Congress of Endocrinology 2022 (ICE2022) 【Online】, which is to be held on August 25th and 28th.
-
NEWS RELEASE
July 28th is World Hepatitis Day!
2022.07.27
In recognition of July 28th being World Hepatitis Day, we here at SMC thought it might be a good idea to help everyone around the globe have a deeper understanding of hepatitis, so please read on if you would like to learn more.
-
PUBLICATION
Drug Efficacy Study in the STAM™ Model Published in Translational Oncology
2022.07.20
SMC is proud to announce that Kurume University (JPN) has published the results of their study using our STAM™ model in Translational Oncology.
